News
Performance
Price return has been average, nothing exciting
Valuation
Seems to be overvalued vs the market average
Growth
Financials growth has been moderate for a few years
Profitability
Average profitability - not good, not bad
Entry point
The stock is underpriced and is not in the overbought zone
Red flags
No red flag found
Go Pro! to unlock score, rank
and other metrics
How to use scorecard? Learn more
Sudarshan Pharma Industries Ltd. to Acquire 100% Stake in Ratna Lifesciences Pvt. Ltd. for ₹5.5 Crore
1 year ago•The Hindu Businessline